BiotechTubeBiotechTube
Home/Aptorum Group/Keith Anderson
KA

Keith Anderson

Chief Operating Officer

Aptorum Group

Therapeutic Areas

OncologyInfectious DiseasesMetabolic DisordersGastrointestinal

Aptorum Group Pipeline

DrugIndicationPhase
SACT-1Neuroblastoma and other solid tumorsPhase 1
ALS-4Staphylococcus aureus infections (including MRSA)Pre-clinical
CLS-1Obesity and Metabolic DisordersDiscovery
NAT-1Various CancersDiscovery
Aptorum Microbiome TherapeuticsClostridioides difficile Infection (CDI)Pre-clinical

Leadership Team at Aptorum Group

DL
Darren Lui
President, Chief Executive Officer & Executive Director
IH
Ian Huen
Chief Financial Officer & Executive Director
CC
Clark Cheng
Chief Scientific Officer & Executive Director
MM
Muzammil Mansuri
Independent Non-Executive Director & Chairman of the Board
DP
David P. Luci
Independent Non-Executive Director
RS
Ronald Shigeta
Independent Non-Executive Director
View full Aptorum Group profile